Aehr Test Systems to Announce Fourth Quarter Fiscal 2017

A Bold Step Forward There's a hearty aroma wafting from Lyon this January, and it's not just from the local gastronomy. Sirha Lyon® is queuing up for its 23rd edition, promising to turn the Foodservice and Hospitality sectors on their heads. Nearly 150,000 square meters of exhibition space packed to the rafters with over 4,300 exhibitors—this ain't your average trade...

Unseen Weakness in Industrial Giants Imagine staring right past a pothole while driving, then wondering why you keep popping your tires. That's where industrial companies find themselves today with critical minerals, according to a new wake-up call from Boston Consulting Group. The giant problem? Firms are blissfully unaware of the mosquitoes in their machines—tiny,...

Fulcra Dynamics Pushes the Boundaries with New Tool There's always that moment when a company nudges the needle, and Fulcra Dynamics seems to have done just that with its latest release. They've unveiled an ingenious tool that promises a shake-up in how we build and use web applications with AI. It's the kind of move that makes you stop and wonder if we're witnessing the...

Skechers Under Fire: Fraud Allegations Surface Alright, if you've been around the stock block a while, you know these stories can often read like a suspense novel. Plot twist: Skechers U.S.A., Inc. (formerly NYSE: SKX) is now facing some serious accusations. There's a class action lawsuit claiming that some shady dealings went down during the company's $9.4 billion...

Gildan's Bumpy Ride: Legal Woes Unfold Well, folks, seems like Gildan Activewear Inc. (NYSE:GIL) is in for a bumpy ride, and not the kind that makes you feel alive, I tell ya. They've been slapped with a class action lawsuit, and the news ain't pretty. Accusations are flying hot about how they've been playing fast and loose with their financials. The Allegations: Channel...

Cracking the Code on TKI Sensitivity When it comes to medicine, sometimes the trickiest part is knowing which button to push—especially in the high-stakes world of metastatic renal cell carcinoma (mRCC). OncoHost just dropped a bombshell at the ESMO 2026 Congress about their new plasma proteomics model that lets us peer into what makes some patients click with Tyrosine...

Bladex's Steady Dividend: What's Under the Hood? Well, well, it looks like Bladex is doing the old dividend dance again. They've just announced a quarterly cash dividend of $0.6875 per share for the third quarter of 2026. It's scheduled for payout on November 24 to those who have their noses in the ledger come November 6—that's your record date, folks. Now, dividends...

If you're looking to invest in an education with promising payoffs, you might look into what's cooking over at Post University. They've just dropped a bombshell of new programs sure to get some attention from tech heads and health nuts alike, and I can't help but think there's potential brewing here. New Academic Paths Emerge Post University isn't resting on its...

Nucor's Solid Third Quarter Performance Nucor Corporation is flexing its muscles, reporting a robust third quarter for 2026. With net earnings hitting $1.32 billion and a diluted earnings per share of $5.80, the steel giant has shown it can more than hold its ground in a competitive market. Compare that to last quarter's $1.16 billion - we're seeing serious momentum....

What's Going On With Surgery Partners? Alright, here's the scoop that shareholders can't ignore—Surgery Partners (NYSE:SGRY) could be heading under the scalpel itself with a proposed buyout by HealthSpan. For those holding onto SGRY stock, this might feel like watching the rerun of a medical drama where the ending ain't clear yet. Shareholders are set to get $23.50 a...

Strategic Moves by Ashcroft Capital for 2025 Ashcroft Capital, a multi-faceted real estate investment firm, is gearing up for an exciting year ahead as it focuses on strategic acquisitions in the multifamily sector. Their latest achievement is the recapitalization of The Avery, a luxurious apartment community renowned for its excellent living standards. The...

BCE Inc. Announces Renewal of Normal Course Issuer Bid BCE Inc. is proud to share that it has secured approval from the Toronto Stock Exchange (the "TSX") for the renewal of its normal course issuer bid ("NCIB"). This program enables BCE to repurchase up to 10% of the public float of its outstanding First Preferred Shares, which are traded on the TSX. Details of the NCIB...

Monopar's Presentation at the American Neurological Association Meeting Monopar Therapeutics Inc. is excited to share groundbreaking new data regarding the long-term neurological efficacy and safety of its investigational therapy, ALXN1840, targeting Wilson disease, at the upcoming 150th American Neurological Association (ANA) Annual Meeting. Renowned neurologist Dr....

Legal Action Against DexCom, Inc. Pomerantz LLP has recently announced a significant class action lawsuit against DexCom, Inc. (NASDAQ: DXCM) and some of its officers. This legal action, which has been filed in a U.S. District Court, aims to represent those individuals and entities who purchased DexCom securities within a specified timeline. The lawsuit seeks to recover...

Red Roof Partners with Canine Companions to Make a Difference Red Roof®, a well-respected name in the lodging industry, is renewing its partnership with Canine Companions to bring a unique initiative called the Room In Your Heart® program to fruition. This program aims not only to offer discounts to travelers but also to support the vital cause of providing trained...